Advanced Therapy Medicinal Products Market - By Product, Diseases, and
End User - Global Industry Insights, Trends, Outlook, and Opportunity
Analysis, 2018-2026
Advanced Therapy Medicinal Products (ATMPs) are innovative therapies that comprises cell
therapy, gene therapy, and tissue engineered products. Cell therapy products include cellular
immunotherapies and autologous and allogeneic cells for certain therapeutic indications including
adult and embryonic stem cells. Whereas, Human gene therapy refers to products that introduce
genetic material into individuals DNA to replace faulty or missing genetic material, thus treating a
disease or abnormal medical condition. These are a novel class of medicines that offer potential
treatment opportunities for diseases that have currently limited or no therapeutic options such as
hemophilia, cystic fibrosis, metabolic disorders, muscular dystrophies, skin burns, Alzheimer, and
cancer. Although majority of ATMPs are in an early stage of development, consolidated trial stage
and the chances to cure chronic conditions signify that ATMPs may achieve the market sooner than
standard treatments. Furthermore, advanced therapy medicinal products are regulated and
authorized for marketing by the Food and Drug Administration (FDA) in the U.S. and by European
Medicines Agency (EMA) in the Europe.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1101
Rising incidences of Alzheimer’s is expected to foster the growth of advanced therapy
medicinal products market
The factors that are contributing the growth of advanced therapy medicinal products market are
rising prevalence of Alzheimer’s disease. According to Alzheimer’s disease International in 2017,
around 50 million people were estimated to suffer from Alzheimer’s disease across the globe.
Furthermore, rising demand for gene therapies used in the treatment of ocular, neurodegenerative
diseases, and several cancers accompanied by technological advancements in genetic engineering
tool such as RNAi are the factors that are expected to boost the growth of advanced therapy
medicinal products market. However, the factors that are hindering the growth of advanced